Rating Agencies
Share recommendations
Made with ❤ von BGFL
#BGFLapp * beta
Valuable background information and well-founded assessments of individual stocks are provided by the studies of the research houses. On this page, Boersengefluester.de (BGFL) provides an integrated overview of all analyst recommendations that come in via the EQS Group newsfeed - enriched with current stock charts as well as meaningful key figure tables and investor information from BGFL. Tip: You are also welcome to use the EQS newsfeed, which we have also enhanced with all the latest company news from our coverage universe.
16.05.2024 09:02AM
Study issued by NuWays AG
Singulus (von NuWays AG): Halten
Halten
Good start into 2024 and strong order intake; chg. est.
Topic: Singulus reported solid Q1 figures with sales and EBIT above our
estimates. Order intake came in strong as already announced on the FY23 CC
in April.
Q1 sales increased 26% yoy to € 20.6m (eNuW: € 18.6m), despite a low order
backlog of € 55m end of FY23. Q1 EBIT sto [ … ]
16.05.2024 09:01AM
Study issued by NuWays AG
bet-at-home AG (von NuWays AG): Halten
Halten
Solid Q1 // indicative decision weighs on the stock; chg
Topic: bet-at-home reported Q1 figures broadly in line with estimates.
Ramped-up marketing spending burdened bottom line but should fuel topline
growth during UEFA EURO championship in Q2/Q3. In detail:
Sales came in at € 11.7m (-12% yoy, 1% qoq), slightly above our estimates
of &e [ … ]
15.05.2024 02:07PM
Study issued by GBC AG
Cenit AG (von GBC AG): BUY
BUY
Q1 2024: Strong start to the current financial year; forecast confirmed;
price target and rating confirmed
CENIT AG has made a good start to the current fiscal year. With sales of €
50.55 million (previous year: € 43.42 million), the previous year's figure
was significantly exceeded by 16.4%. Even though inorganic effects
contrib [ … ]
15.05.2024 09:36AM
Study issued by NuWays AG
INDUS Holding AG (von NuWays AG): Kaufen
Kaufen
Mixed Q1 results // strong FCF generation; chg. est.
Topic: INDUS reported a mixed Q1 with sales below but EBIT above estimates
as well as strong free cashflow supported by a lower seasonal working
capital increase.
Q1 sales decreased by 9% yoy to € 410m (eNuW: € 434m) due to customers’
current reluctance to buy and spend as a [ … ]
15.05.2024 09:31AM
Study issued by NuWays AG
MAX Automation SE (von NuWays AG): Kaufen
Kaufen
Muted start into the year but solid order intake; chg. est.
Topic: MAX released mixed Q1 results with muted sales and slight pressure
on margins in line with expectations. However, order intake moderately
improved qoq from a low level in the last three quarters
supported by continuous follow-up orders from ELWEMA.
Q1 group sales declined slig [ … ]
14.05.2024 09:06AM
Study issued by NuWays AG
CR Energy AG (von NuWays AG): Kaufen
Kaufen
Final FY slightly ahead of preliminary figures / chg.
CR Energy published its FY ’23 report, displaying figures slightly ahead of
the prelims published in March. In detail:
FY ’23 sales, which refers mainly to income from the investment business,
came in at € 68.8m, implying a 14% yoy decline. The decline can be mainly
explai [ … ]
14.05.2024 09:01AM
Study issued by NuWays AG
q.beyond AG (von NuWays AG): Kaufen
Kaufen
Strong Q1 figures hint towards successful transformation/ chg.
Yesterday, q.beyond released a strong set of Q1 figures, which exceeded
ours and streets profitability estimates as efficiency measures bore fruit
despite rather muted top-line growth. In detail:
Q1 sales increased slightly by 1.1% yoy to € 47.1m (eNuW: €47.5m, eCons: &e [ … ]
13.05.2024 11:41AM
Study issued by First Berlin Equity Research GmbH
Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
Buy
First Berlin Equity Research has published a research update on Schloss
Wachenheim AG (ISIN: DE0007229007). Analyst Simon Scholes reiterated his
BUY rating and maintained his EUR 22.00 price target.
Abstract:
Q3 23/24 sales climbed 5.6% to €87.1m (Q3 22/23: €82.5m) as price rises and
positive product mix and currency effects outweighe [ … ]
13.05.2024 09:02AM
Study issued by NuWays AG
MLP SE (von NuWays AG): Kaufen
Kaufen
Q1 preview: performance fees and banking to drive EBIT
Topic: MLP's Q1 results are due on Wednesday, May 15th and we expect a
solid EBIT expansion driven by a contribution of performance fees (first
time since Q4'21) as well as continuous support from the banking business.
In detail:
Solid top-line: For Q1, we expect sales to grow by 7% to &e [ … ]
10.05.2024 12:41PM
Study issued by First Berlin Equity Research GmbH
MPH Health Care AG (von First Berlin Equity Research GmbH): Kaufen
Kaufen
First Berlin Equity Research hat ein Research Update zu MPH Health Care AG
(ISIN: DE000A289V03) veröffentlicht. Analyst Ellis Acklin bestätigt seine
BUY-Empfehlung und erhöht das Kursziel von EUR 62,00 auf EUR 81,00.
Zusammenfassung:
Die vorläufigen Ergebnisse entsprachen weitgehend unseren Erwartungen. Der
JE23 Nettoinventa [ … ]
Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
We have summarised companies with a market capitalisation of more than EUR 1 billion that are not included in any index under X-Caps.
Dataselect Tool Family
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies 
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL